The Effect of Lipopolysaccharide, Interleukin-1 and Tumour Necrosis Factor on the Hepatic Accumulation of 5-hydroxytryptamine and Platelets in the Mouse

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1992 Mar 1

PMID 1628148

Citations 24

Authors

Y Endo

M Nakamura

Affiliations

Soon will be listed here.

Abstract

1. Injection of lipopolysaccharide (LPS; 0.5-500 microgram kg-1) into mice induced a dose-dependent, slowly developing increase in hepatic content of 5-hydroxytryptamine (5-HT). This sustained increase could not be attributed to an LPS-induced alteration of the pharmacokinetic handling of 5-HT by stimulation of its uptake or inhibition of its degradation. 2. Regional differences were apparent in the tissue content of histamine and 5-HT between mast cell-deficient (W/Wv) and normal (+/+) mice. LPS administration (0.5 mg kg-1) gave comparable increases in the hepatic level of 5-HT in mast cell-deficient and normal mice. 3. Reserpine pretreatment (1 mg kg-1) selectively reduced 5-HT levels in the blood, spleen, liver, brain and lung of normal mice. Prior treatment with this agent also abolished the LPS (0.5 mg kg-1)-induced hepatic accumulation of 5-HT. 4. Accumulation of 5-HT in the liver by LPS (0.1 mg kg-1) was temporally associated with both a fall in the levels of circulating platelets, and a reduction in the concentration of 5-HT in the blood. The LPS dose-dependent (0.5-500 micrograms kg-1) increase in hepatic 5-HT content was associated with a similar dose-dependent reduction in the circulating levels of 5-HT. 5. Interleukin-1, alpha and beta (10 micrograms kg-1) and tumour necrosis factor alpha (TNF alpha) (1 mg kg-1) significantly enhanced the accumulation of 5-HT within the liver. Administration of TNF alpha (10 micrograms kg-1) potentiated the increase in hepatic 5-HT content seen with IL-1 beta (10 micrograms kg-1). 6. Electron microscopy revealed numerous platelets in the sinusoidal and perisinusoidal Disse spaces within the liver, in animals pretreated with LPS (0.1 mg kg '). The platelets retained their intact structure and showed no evidence of degranulation. 7. These data suggest that the LPS and cytokine-induced mobilization of 5-HT in the liver is associated with the hepatic translocation of platelets. This migration appears to be independent of platelet aggregation.

Citing Articles

Lipopolysaccharide Effects on Neurotransmission: Understanding Implications for Depression.

Batey L, Baumberger B, Khoshbouei H, Hashemi P ACS Chem Neurosci. 2024; 15(24):4339-4347.

PMID: 39601433 PMC: 11660149. DOI: 10.1021/acschemneuro.4c00591.

IL-33 induces histidine decarboxylase, especially in c-kit cells and mast cells, and roles of histamine include negative regulation of IL-33-induced eosinophilia.

Bando K, Tanaka Y, Winias S, Sugawara S, Mizoguchi I, Endo Y Inflamm Res. 2023; 72(3):651-667.

PMID: 36723628 DOI: 10.1007/s00011-023-01699-y.

Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis.

Miao S, Lu M, Liu Y, Shu D, Zhu Y, Song W Mol Oncol. 2020; 14(10):2546-2559.

PMID: 32799418 PMC: 7530782. DOI: 10.1002/1878-0261.12783.

Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

de Haan L, van der Lely S, Warps A, Hofsink Q, Olthof P, de Keijzer M J Clin Transl Res. 2019; 4(1):1-46.

PMID: 30761355 PMC: 6370335. DOI: 10.18053/jctres.04.201801.001.

Start a fire, kill the bug: The role of platelets in inflammation and infection.

Deppermann C, Kubes P Innate Immun. 2018; 24(6):335-348.

PMID: 30049243 PMC: 6830908. DOI: 10.1177/1753425918789255.

References

Kikumoto Y, Hong Y, Nishida T, Nakai S, Masui Y, Hirai Y . Purification and characterization of recombinant human interleukin-1 beta produced in Escherichia coli. Biochem Biophys Res Commun. 1987; 147(1):315-21. DOI: 10.1016/s0006-291x(87)80123-7. View

Mathison J, Wolfson E, Ulevitch R . Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest. 1988; 81(6):1925-37. PMC: 442645. DOI: 10.1172/JCI113540. View

Old L . Tumour necrosis factor. Polypeptide mediator network. Nature. 1987; 326(6111):330-1. DOI: 10.1038/326330a0. View

CARSTAIRS K . The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol. 1965; 90(1):225-31. DOI: 10.1002/path.1700900124. View

Ulevitch R, Cochrane C, Henson P, Morrison D, Doe W . Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med. 1975; 142(6):1570-90. PMC: 2190070. DOI: 10.1084/jem.142.6.1570. View

Davis R . Electron microscopic changes in blood platelets induced by bacterial lipopolysaccharide. Exp Mol Pathol. 1966; 5(6):559-74. DOI: 10.1016/0014-4800(66)90046-3. View

Iff E, Vaz N . Mechanisms of anaphylaxis in the mouse. Similarity of shock induced by anaphylaxis and by mixtures of histamine and serotonin. Int Arch Allergy Appl Immunol. 1966; 30(4):313-22. DOI: 10.1159/000229815. View

Endo Y, Suzuki R, Kumagai K . Macrophages can produce factors capable of inducing histidine decarboxylase, a histamine-forming enzyme, in vivo in the liver, spleen, and lung of mice. Cell Immunol. 1986; 97(1):13-22. DOI: 10.1016/0008-8749(86)90370-9. View

Lehmann V, Freudenberg M, Galanos C . Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987; 165(3):657-63. PMC: 2188282. DOI: 10.1084/jem.165.3.657. View

10.

Endo Y, Suzuki R, Kumagai K . Interleukin 1-like factors can accumulate 5-hydroxytryptamine in the liver of mice and can induce hypoglycaemia. Biochim Biophys Acta. 1985; 840(1):37-42. DOI: 10.1016/0304-4165(85)90159-x. View

11.

Endo Y . A lipopolysaccharide and concanavalin A induce variations of serotonin levels in mouse tissues. Eur J Pharmacol. 1983; 91(4):493-9. DOI: 10.1016/0014-2999(83)90175-9. View

12.

Tadano T, Endo Y, Kisara K . A simple determination of serotonin, 5-hydroxyindoleacetic acid and 5-hydroxytryptophan decarboxylase activity in rat brain areas and parallel correlation among the levels. Jpn J Pharmacol. 1980; 30(3):347-56. DOI: 10.1254/jjp.30.347. View

13.

Endo Y . Induction of hypoglycaemia and accumulation of 5-hydroxytryptamine in the liver after the injection of mitogenic substances into mice. Br J Pharmacol. 1984; 81(4):645-50. PMC: 1986911. DOI: 10.1111/j.1476-5381.1984.tb16130.x. View

14.

Endo Y . Induction of histidine decarboxylase in mouse tissues by mitogens in vivo. Biochem Pharmacol. 1983; 32(24):3835-8. DOI: 10.1016/0006-2952(83)90157-0. View

15.

Endo Y . A simple method for the determination of polyamines and histamine and its application to the assay of ornithine and histidine decarboxylase activities. Methods Enzymol. 1983; 94:42-7. DOI: 10.1016/s0076-6879(83)94008-9. View

16.

Endo Y . Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice. Biochem Pharmacol. 1982; 31(8):1643-7. DOI: 10.1016/0006-2952(82)90394-x. View

17.

Yamatodani A, Maeyama K, Watanabe T, Wada H, Kitamura Y . Tissue distribution of histamine in a mutant mouse deficient in mast cells: clear evidence for the presence of non-mast-cell histamine. Biochem Pharmacol. 1982; 31(3):305-9. DOI: 10.1016/0006-2952(82)90175-7. View

18.

Mathison J, Ulevitch R . In vivo interaction of bacterial lipopolysaccharide (LPS) with rabbit platelets: modulation by C3 and high density lipoproteins. J Immunol. 1981; 126(4):1575-80. View

19.

Galanos C, Freudenberg M, REUTTER W . Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A. 1979; 76(11):5939-43. PMC: 411768. DOI: 10.1073/pnas.76.11.5939. View

20.

Ulevitch R, Cochrane C, Bangs K, HERMAN C, Fletcher J, Rice C . The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey. Am J Pathol. 1978; 92(1):227-40. PMC: 2018583. View